Epidemiology of AIDS in the World and in Vugoslavia
DOI:
https://doi.org/10.5644/Radovi.280Abstract
The authors are giving a review of the results reached so far in research of etiologic agent, infection mechanisms. clinical manifestations and the prevention of AIDS in the world and in Yugoslavia.
This study gets numerical and territorial expan.se of this disease in the USA, in African countries and the other parts of the world.
In Yugoslavia, by February 1989, there were 74 registered cases of AIDS with 35 lethal cases.
It is considered that IV drug users are the main possible transmitters of AIDS in our country.
Among 124 000 healthy blood donors there have been found 4 (0.003%) seropositive persons.
Within the past two years significant preventive and epidemic measures have been carried out in Yugoslavia under the guidance of the Federal Anti-AIDS Commission. These measures have been carried out in three directions:
- wide public education on this disease and the importance of condoms in personal protection,
- organizing and establishing serologic laboratories for Elisa testing, as well as specific education of health and other personnel in prevention of this disease,
- emphasising that AIDS is not only a health problem, but that it is as well an extremely significant social problem.
References
Centers for Disease Control: Pneumocystis Pneumonia. Los Angeles MMWR 30 : 250, 1981.
Centers for Dissease Control: Kaposi’s Sarcoma, Pneumocystis Pneumonia Among Homosexual Men-New York City and Califomia, MMWR, 30 :350—308, 1981.
Barre-Sinoussi, F., Chermann, J. C., Rey, F. et al.: Isolation of a T-lymphotropic Retrovirus From a Patient at Risk for Acguired Immzine Deficiencg Syndrome (AIDS). Science. 220:868-871, 1933.
Safai, B., Sarngadharan, M. G., Groopman, J. E. et al.: Seroepidemiological Studies of Human T-lymphotropic Retrovirus Type III in Acquired Immunodeficiencg Sundrome. Lancet, 1 :1438-1440, 1984.
Sarngadharam,. M. G., Popović, M., Bruch, L. et al.: Antibodies Reactive With Human T LymphoAropic Retrovirus (HTLV/III) in the Serum of Patients with AIDS. Science, 224 :50G-508, 1984.
AIDS ALERT: Scientists Discover Third AIDS, Vol. 1, N° 12, 209—224, 1986.
Thomas, A., Peterman, Drotman, D. and Currass W.: Epidemioloy of the Acguired Immunodeficiency Syndrome (AIDS). Epid. Reviews, Vol. 7r 1—21, 1985.
Saxinger, C., Gulio, R. C.: Methods in Laboratory Investigation: Application of the Indirect Enzymo-linked Immunoadsorbent Assay Microtest to the Detection and Surveillance of Human T-lymphothic Leukemia-lymphoma Virus. Lab. invest 49 :371—377, 1983.
Health for Ali — Smjernice za SIDU (AIDS) u Evropi. Institut za socijalnu medicinu, organizaciju i ekonomiku zdravstva, Sarajevo, 1986.
Murray, A. W., Rubin, B. Y., Masur, H., et al. : Impaired Production of Lijmphokines and Immune (Gamma) Interferon in the Aguired Immunodeficiency Syndrome. N. Engl. Y. Med. 310 : 883—889, 1984.
Lane, H. C., Masur, H., Edgar L. C., et al.: Abnormalities of B-cell Activation and Immunoregulation in Patients with the Acguired Immunodeficiency Syndrome. N. Eng. Y. Med. 309—453—358, 1983.
Gupta, S., Licorish, K.: Circulating Immune Compleies in AIDS. N. Engl. Y. Med. 310 :1530-1531, 1984.
World Health Organisation: Acguired Immunodeficiency Syndrome (AIDS). WHO/CDC case definition for AIDS. Wsly. Epidem. Rec. 61:69—73, 1986.
Volberding, P.: AIDS-vccination on a Theme of Cellular Immune Deficiency. Međunarodni Simp. za SIDU, Pariš, maj, 1986.
CDC: Pneumocystis Pneumonia. Los Angeles, Morbidity and Mortality Weekly Report 30 : 250—252, 1981.
CDC: Kaposi’s Sarcoma and Pneumocystis Pneumonia Among Homosexual Men — New York and California. Morbidity and Mortality Weekly Report 30 : 305—308. 1981.
Amstrong, D., Gold, J. W., Dryjanski, J. et al.: Tretment of Infections in Patients with the Accguired Immune Deficiency Syndrome. Annals of Int. Med. 103 :738-743, 1985.
Rivin, B. E., Monroe, J.M., Hubschman, B. P. et al.: AIDS Outcome: a First Follow Up (Lether). N. Eng. Y. Med. 311 :857, 1984.
CDR — The Acguired Immune Deficiency Syndrome. 3—6, April, 1986.
Jesson. W., Thorp, R. N., Mortimer, P.P., Oates, J.K.: Prevalence of Anti-HTLV/III in UK Risk Groops 1984/1985. Lancet 155—156, 1984/85.
Cheingsong-Popov, R., Weiss, R. A., Dalglish, A. et al.: Prevalence of Antibody to Human T-lymphotropic Virus Type III in AIDS and AID-risk Patients in Britain. Lancet, 477—480, 1984.
Bigaar, R.J.: The AIDS Problem in Afrika. Lancet, 79—83, 1986.
Teder, R.S., Uttley, A., Cheingsong-Popov. R.: Safety of Immunoglobulin Preparation Contamining Anti-HTLV/III. Lancet 815—816, 1985.
Curran, I. W., Morgan, W. D., Hardy, A. M. et al.: Epidemiology of AIDS. Science 229 :1332—1337, 1985.
Centers for Disease Control: Recommendation for Assisting in the Prevention of Perinatal Transmision of Human L-lymphotropic Virus Type III (Lymphodentopatihy — Associated Virus and Acguired Immunodeficiency Syndrome. MMWR, 34 : 731—732, 1985.
C. D. C.: Lymphodenopathy — Associated Virus Infection in Health Care Personnel-United States. MMWR. 34 :375—79, 1985.
Smithies, A.: Acguired Immunodeficency Syndrom (AIDS) HTLV / III-LAV; the Causal Agent and Model of Transmission. Health Trends, 18 :19—21, 1986.
Gaon, J.: Sta treba znati o SIDI, Zadrugar, Sarajevo, 1987.
CDR: Acguired Immunodeficiency Syndrom United Kingdom, Jan. 1987.
CDR: HIV Infections In Health Care Workers. 87/20, 22nd Mac 1987.
CDS: Additional Recommendition tb Reduce Sexudl and Drug Abuse — Related Transmission of Human T-limphotropic Virus Type III (Lymphodenopathy — Associated Virus). MMWR 35:152—155, 1986.
MMWR: Human Immunodeficiencg Virus Infection in Transfusion Accipients and Their Family Members. Vol. 36/N° 10, March, 20, 1987.
MMWR: Up date: Human Immunodeficiency Virus Ifnections in Health-core Workers Exposed to Blood of Infected Patients. Nd. 36/n° 19, May 22, 1987.
Službeni list SFRJ 51/84: Odluka za zaštitu stanovništva od sindroma stečenog nedostatka imuniteta. Beograd, 1984.
Meldrum, J.: AIDS Informations Dienst: LAVVSHTLV, London, April, 1986.
WKLy-Epid. Rec. N° 23, 5 june 1987.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Boriša S. Telebak, Jakob A. Gaon, Dejan Gaon
This work is licensed under a Creative Commons Attribution 4.0 International License.
